Trial Profile
Evaluation of the efficacy and safety of sugammadex (Bridion) in children with renal failure.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 02 Aug 2022
Price :
$35
*
At a glance
- Drugs Sugammadex (Primary)
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 30 Jul 2022 Status changed from not stated to discontinued.
- 05 Oct 2017 New trial record